• 31069 Citations
  • 94 Scopus h-Index
19962020
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1996 2019

2015
12 Citations (Scopus)

Carfilzomib: A cause of drug associated thrombotic microangiopathy

Qaqish, I., Schlam, I. M., Chakkera, H. M., Fonseca, R. & Adamski, J., Aug 24 2015, (Accepted/In press) In : Transfusion and Apheresis Science.

Research output: Contribution to journalArticle

Thrombotic Microangiopathies
Plasma Exchange
Multiple Myeloma
Pharmaceutical Preparations
Therapeutics
35 Citations (Scopus)

Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia

Ojha, J., Ayres, J., Secreto, C., Tschumper, R., Rabe, K., Van Dyke, D., Slager, S. L., Shanafelt, T., Fonseca, R., Kay, N. E. & Braggio, E. D., Jan 15 2015, In : Blood. 125, 3, p. 492-498 7 p.

Research output: Contribution to journalArticle

High-Throughput Nucleotide Sequencing
Genetic Heterogeneity
B-Cell Chronic Lymphocytic Leukemia
Genes
Microarrays
89 Citations (Scopus)

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Mayo Phase Consortium, Jan 15 2015, In : Blood. 125, 3, p. 443-448 6 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinases
Multiple Myeloma
CDC2 Protein Kinase
Proteasome Inhibitors
Stabilization
3 Citations (Scopus)

Extramedullary Cardiac Multiple Myeloma-A Case Report and Contemporary Review of the Literature

Coakley, M., Yeneneh, B., Rosenthal, A., Fonseca, R. & Mookadam, F., Nov 29 2015, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Plasmacytoma
Takotsubo Cardiomyopathy
Recurrence
Cardiac Tamponade
74 Citations (Scopus)

Genome-wide analysis uncovers novel recurrent alterations in primary central nervous system lymphomas

Braggio, E. D., Van Wier, S., Ojha, J., McPhail, E., Asmann, Y., Egan, J., Da Silva, J. A., Schiff, D., Lopes, M. B., Decker, P. A., Valdez, R., Tibes, R., Eckloff, B., Witzig, T. E., Stewart, A. K., Fonseca, R. & O'Neill, B. P., Sep 1 2015, In : Clinical Cancer Research. 21, 17, p. 3986-3994 9 p.

Research output: Contribution to journalArticle

Lymphoma
Central Nervous System
Genome
Lymphoma, Large B-Cell, Diffuse
Exome
31 Citations (Scopus)

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

Bi, C., Chung, T. H., Huang, G., Zhou, J., Yan, J., Ahmann, G. J., Fonseca, R. & Chng, W. J., 2015, In : Oncotarget. 6, 28, p. 26508-26518 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
MicroRNAs
Genome
Neoplasms
Epigenomics
19 Citations (Scopus)

Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia

Ojha, J., Secreto, C. R., Rabe, K. G., Van Dyke, D. L., Kortum, K. M., Slager, S. L., Shanafelt, T. D., Fonseca, R., Kay, N. E. & Braggio, E. D., May 1 2015, In : British Journal of Haematology. 169, 3, p. 445-448 4 p.

Research output: Contribution to journalArticle

DEAD-box RNA Helicases
B-Cell Chronic Lymphocytic Leukemia
Genomics
Tumor Suppressor Genes
Mutation
23 Citations (Scopus)

Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M<sup>3</sup>P)

Kortüm, K. M., Langer, C., Monge, J., Bruins, L., Zhu, Y. X., Shi, C. X., Jedlowski, P., Egan, J. B., Ojha, J., Bullinger, L., Kull, M., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H., Stewart, A. K. & Braggio, E. D., Jul 18 2015, In : Annals of Hematology. 94, 7, p. 1205-1211 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Mutation
Genes
Clonal Evolution
Gene Targeting
43 Citations (Scopus)

Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myeloma

Stewart, A. K., Jacobus, S., Fonseca, R., Weiss, M., Callander, N. S., Chanan Khan, A. A. & Rajkumar, S. V., Sep 10 2015, In : Blood. 126, 11, p. 1294-1301 8 p.

Research output: Contribution to journalArticle

Melphalan
Thalidomide
Oncology
Prednisone
Multiple Myeloma
46 Citations (Scopus)

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib

Kumar, S. K., Laplant, B., Roy, V., Reeder, C. B., Lacy, M., Gertz, M., Laumann, K., Thompson, M. A., Witzig, T. E., Buadi, F. K., Rivera, C. E., Mikhael, J. R., Bergsagel, P. L., Kapoor, P., Hwa, L., Fonseca, R., Stewart, A. K., Chanan Khan, A. A., Rajkumar, S. V. & Dispenzieri, A., Aug 14 2015, In : Blood Cancer Journal. 4, e338.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Bortezomib
ixazomib
Proteasome Inhibitors
3 Citations (Scopus)
Antineoplastic Combined Chemotherapy Protocols
Melphalan
Thalidomide
Stem Cell Transplantation
Prednisone
32 Citations (Scopus)

Targeted sequencing using a 47 gene multiple myeloma mutation panel (M3P) in -17p high risk disease

Kortüm, K. M., Langer, C., Monge, J., Bruins, L., Egan, J. B., Zhu, Y. X., Shi, C. X., Jedlowski, P., Schmidt, J., Ojha, J., Bullinger, L., Liebisch, P., Kull, M., Champion, M. D., Van Wier, S., Ahmann, G., Rasche, L., Knop, S., Fonseca, R., Einsele, H. & 2 others, Stewart, A. K. & Braggio, E. D., Feb 1 2015, In : British Journal of Haematology. 168, 4, p. 507-510 4 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Mutation
Genes
57 Citations (Scopus)

Treatment of Immunoglobulin Light Chain Amyloidosis Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

Dispenzieri, A., Buadi, F., Kumar, S. K., Reeder, C. B., Sher, T., Lacy, M., Kyle, R. A., Mikhael, J. R., Roy, V., Leung, N., Grogan, M., Kapoor, P., Lust, J. A., Dingli, D. M., Go, R. S., Hwa, Y. L., Hayman, S. R., Fonseca, R., Ailawadhi, S., Bergsagel, P. L. & 6 others, Chanan Khan, A. A., Rajkumar, S. V., Russell, S. J., Stewart, A. K., Zeldenrust, S. R. & Gertz, M., Aug 1 2015, In : Mayo Clinic Proceedings. 90, 8, p. 1054-1081 28 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
Amyloidosis
Consensus
Expert Testimony
Therapeutics
2014
7 Citations (Scopus)

Absence of tissue factor is characteristic of lymphoid malignancies of both T- and B-cell origin

Cesarman-Maus, G., Braggio, E. D., Lome-Maldonado, C., Morales-Leyte, A. L. & Fonseca, R., 2014, In : Thrombosis Research. 133, 4, p. 606-609 4 p.

Research output: Contribution to journalArticle

Thromboplastin
B-Lymphocytes
Neoplasms
Thrombosis
Lymphoma
49 Citations (Scopus)

Activation of TAK1 by MYD88 L265P drives malignant B-cell growth in non-Hodgkin lymphoma

Ansell, S. M., Hodge, L. S., Secreto, F. J., Manske, M., Braggio, E. D., Price-Troska, T., Ziesmer, S., Li, Y., Johnson, S. H., Hart, S., Kocher, J-P., Vasmatzis, G., Chanan Khan, A. A., Gertz, M., Fonseca, R., Dogan, A., Cerhan, J. R. & Novak, A. J., 2014, In : Blood Cancer Journal. 4, 2, 20144.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Non-Hodgkin's Lymphoma
B-Lymphocytes
Growth
TNF Receptor-Associated Factor 6
11 Citations (Scopus)

Activity of 129 single-agent drugs in 228 phase i and II clinical trials in multiple myeloma

Kortuem, K. M., Zidich, K., Schuster, S. R., Khan, M. L., Jimenez-Zepeda, V. H., Mikhael, J. R., Fonseca, R. & Stewart, A. K., 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 4, p. 284-290 7 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Multiple Myeloma
Pharmaceutical Preparations
fotemustine
Teniposide

Amitriptyline-induced agranulocytosis with bone marrow confirmation

Azadeh, N., Kelemen, K. & Fonseca, R., Oct 1 2014, In : Clinical Lymphoma, Myeloma and Leukemia. 14, 5, p. e183-e185

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Boronic Acids
Pyrazines
Febrile Neutropenia
Spontaneous Fractures
89 Citations (Scopus)

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Zhu, Y. X., Braggio, E. D., Shi, C. X., Kortuem, K. M., Bruins, L. A., Schmidt, J. E., Chang, X-B. D., Langlais, P. R., Luo, M., Jedlowski, P., LaPlant, B., Laumann, K., Fonseca, R., Bergsagel, P. L., Mikhael, J. R., Lacy, M., Champion, M. D. & Stewart, A. K., Jul 24 2014, In : Blood. 124, 4, p. 536-545 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Carrier Proteins
Survival
Cells
Ports and harbors
40 Citations (Scopus)

Implementing individualized medicine into the medical practice

Lazaridis, K. N., MCAllister, T. M., Babovic-Vuksanovic, D., Beck, S. A., Borad, M. J., Bryce, A. H., Chanan Khan, A. A., Ferber, M. J., Fonseca, R., Johnson, K. J., Klee, E. W., Lindor, N. M., MCCormick, J. B., Mc Williams, R. R., Parker, A., Riegert-Johnson, D. L., Rohrer Vitek, C. R., Schahl, K. A., Schultz, C., Stewart, A. K. & 3 others, Then, G. C., Wieben, E. D. & Farrugia, G., 2014, In : American Journal of Medical Genetics, Part C: Seminars in Medical Genetics. 166, 1, p. 15-23 9 p.

Research output: Contribution to journalArticle

Precision Medicine
Medicine
Patient Care
Exome
Workflow
271 Citations (Scopus)

IMWG consensus on risk stratification in multiple myeloma

Chng, W. J., Dispenzieri, A., Chim, C. S., Fonseca, R., Goldschmidt, H., Lentzsch, S., Munshi, N., Palumbo, A., Miguel, J. S., Sonneveld, P., Cavo, M., Usmani, S., Durie, B. G. & Avet-Loiseau, H., Feb 2014, In : Leukemia. 28, 2, p. 269-277 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Therapeutics
Clinical Trials
161 Citations (Scopus)

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

Borad, M. J., Champion, M. D., Egan, J. B., Liang, W. S., Fonseca, R., Bryce, A. H., McCullough, A. E., Barrett, M., Hunt, K., Patel, M. D., Young, S. W., Collins, J. M., Silva, A. C., Condjella, R. M., Block, M. S., Mc Williams, R. R., Lazaridis, K. N., Klee, E. W., Bible, K. C., Harris, P. & 29 others, Oliver, G. R., Bhavsar, J. D., Nair, A. A., Middha, S., Asmann, Y., Kocher, J-P., Schahl, K., Kipp, B. R., Barr Fritcher, E. G., Baker, A., Aldrich, J., Kurdoglu, A., Izatt, T., Christoforides, A., Cherni, I., Nasser, S., Reiman, R., Phillips, L., McDonald, J., Adkins, J., Mastrian, S. D., Placek, P., Watanabe, A. T., LoBello, J., Han, H., Von Hoff, D., Craig, D. W., Stewart, A. K. & Carpten, J. D., Feb 2014, In : PLoS Genetics. 10, 2, e1004135.

Research output: Contribution to journalArticle

Cholangiocarcinoma
tumor
genomics
drug
inhibitor
37 Citations (Scopus)

Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States

Mereuta, O. M., Theis, J. D., Vrana, J. A., Law, M. E., Grogg, K. L., Dasari, S., Chandan, V. S., Wu, T. T., Jimenez-Zepeda, V. H., Fonseca, R., Dispenzieri, A., Kurtin, P. J. & Dogan, A., Mar 6 2014, In : Blood. 123, 10, p. 1479-1482 4 p.

Research output: Contribution to journalArticle

Chemotactic Factors
Amyloidosis
Amyloid
Leukocytes
Liver
30 Citations (Scopus)

Long-term survival with cyclophosphamide, bortezomib and dexamethasone induction therapy in patients with newly diagnosed multiple myeloma

Reeder, C. B., Reece, D. E., Kukreti, V., Mikhael, J. R., Chen, C., Trudel, S., Laumann, K., Vohra, H., Fonseca, R., Bergsagel, P. L., Leis, J. F., Tiedemann, R. & Stewart, A. K., Nov 1 2014, In : British Journal of Haematology. 167, 4, p. 563-565 3 p.

Research output: Contribution to journalArticle

Antineoplastic Combined Chemotherapy Protocols
Boronic Acids
Pyrazines
Multiple Myeloma
Cyclophosphamide

Molecular classification and risk stratifiCation

Kumar, S. K., Fonseca, R. & Stewart, A. K., Jan 1 2014, Multiple Myeloma: Diagnosis and Treatment. Springer New York, p. 55-64 10 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Plasma Cells
Fluorescence In Situ Hybridization
Cytogenetics
Naphazoline
RNA Sequence Analysis
30 Citations (Scopus)

Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression

Ojha, J., Secreto, C., Rabe, K., Ayres-Silva, J., Tschumper, R., Dyke, D. V., Slager, S. L., Fonseca, R., Shanafelt, T., Kay, N. E. & Braggio, E. D., Jul 18 2014, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Clonal Evolution
Lymphocytosis
B-Cell Chronic Lymphocytic Leukemia
Disease Progression
B-Lymphocytes
44 Citations (Scopus)

p53 haploinsufficiency and functional abnormalities in multiple myeloma

Teoh, P. J., Chung, T. H., Sebastian, S., Choo, S. N., Yan, J., Ng, S. B., Fonseca, R. & Chng, W. J., Oct 1 2014, In : Leukemia. 28, 10, p. 2066-2074 9 p.

Research output: Contribution to journalArticle

Haploinsufficiency
Multiple Myeloma
p53 Genes
Genes
Alleles
17 Citations (Scopus)

Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition

Gordon, G. W., Monge, J., Channon, M. B., Wu, Q., Skulan, J. L., Anbar, A. D. & Fonseca, R., Oct 1 2014, In : Leukemia. 28, 10, p. 2112-2115 4 p.

Research output: Contribution to journalArticle

Neoplastic Gene Expression Regulation
Calcium Isotopes
Diphosphonates
Tumor Biomarkers
Multiple Myeloma
121 Citations (Scopus)

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

Affer, M., Chesi, M., Chen, W. D., Keats, J. J., Demchenko, Y. N., Tamizhmani, K., Garbitt, V. M., Riggs, D. L., Brents, L. A., Roschke, A. V., Van Wier, S., Fonseca, R., Bergsagel, P. L. & Kuehl, W. M., 2014, In : Leukemia. 28, 8, p. 1725-1735 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Germinal Center
Immunoglobulin Genes
Neoplasms
20 Citations (Scopus)

Staging and prognostication of multiple myeloma

Fonseca, R., Monge, J. & Dimopoulos, M. A., Feb 2014, In : Expert Review of Hematology. 7, 1, p. 21-31 11 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Disease Management
Survival
Therapeutics
55 Citations (Scopus)

The clinical significance of cereblon expression in multiple myeloma

Schuster, S. R., Kortuem, K. M., Zhu, Y. X., Braggio, E. D., Shi, C. X., Bruins, L. A., Schmidt, J. E., Ahmann, G., Kumar, S. K., Rajkumar, S. V., Mikhael, J. R., LaPlant, B., Champion, M. D., Laumann, K., Barlogie, B., Fonseca, R., Bergsagel, P. L., Lacy, M. & Stewart, A. K., Jan 2014, In : Leukemia Research. 38, 1, p. 23-28 6 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Biomarkers
Survival
Pharmaceutical Preparations

Trisomies in multiple myeloma: Impact on survival in patients with high-risk cytogenetics. (Blood (2012) 119, 9 (2100-2105))

Kumar, S. K., Fonseca, R. & Ketterling, R. P., Mar 6 2014, In : Blood. 123, 10, p. 1621 1 p.

Research output: Contribution to journalArticle

Trisomy
Multiple Myeloma
Cytogenetics
Survival
8 Citations (Scopus)

Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements

Egan, J. B., Barrett, M., Champion, M. D., Middha, S., Lenkiewicz, E., Evers, L., Francis, P., Schmidt, J., Shi, C. X., Van Wier, S., Badar, S., Ahmann, G., Kortuem, K. M., Boczek, N. J., Fonseca, R., Craig, D. W., Carpten, J. D., Borad, M. J. & Stewart, A. K., Feb 5 2014, In : PLoS One. 9, 2, e87113.

Research output: Contribution to journalArticle

Liposarcoma
gene fusion
Genes
aneuploidy
Genome
2013
24 Citations (Scopus)

A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma

Chung, T. H., Mulligan, G., Fonseca, R. & Chng, W. J., Jun 20 2013, In : PLoS One. 8, 6, e66361.

Research output: Contribution to journalArticle

Chromosomal Instability
myeloma
Chromosomes
Multiple Myeloma
Transcriptome
2 Citations (Scopus)

CGH protocols: chronic lymphocytic leukemia.

Braggio, E. D., Fonseca, R. & Kay, N. E., 2013, In : Methods in molecular biology (Clifton, N.J.). 973, p. 87-98 12 p.

Research output: Contribution to journalArticle

Comparative Genomic Hybridization
B-Cell Chronic Lymphocytic Leukemia
Workflow
Genome
Research
125 Citations (Scopus)

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: An International Myeloma Working Group collaborative project

Avet-Loiseau, H., Durie, B. G. M., Cavo, M., Attal, M., Gutierrez, N., Haessler, J., Goldschmidt, H., Hajek, R., Lee, J. H., Sezer, O., Barlogie, B., Crowley, J., Fonseca, R., Testoni, N., Ross, F., Rajkumar, S. V., Sonneveld, P., Lahuerta, J., Moreau, P. & Morgan, G., Mar 2013, In : Leukemia. 27, 3, p. 711-717 7 p.

Research output: Contribution to journalArticle

Fluorescence In Situ Hybridization
Cytogenetics
Chromosome Aberrations
Survival
Disease-Free Survival

Cytogenetic abnormalities in MGUS and myeloma

Fonseca, R., Bergsagel, P. L. & Kuehl, W. M., Nov 1 2013, Neoplastic Diseases of the Blood. Springer New York, p. 589-599 11 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Multiple Myeloma
Chromosome Aberrations
Polyploidy
Trisomy
Chromosomes
4 Citations (Scopus)

Dissecting karyotypic patterns in non-hyperdiploid multiple myeloma: An overview on the karyotypic evolution

Jimenez-Zepeda, V. H., Braggio, E. D. & Fonseca, R., Oct 2013, In : Clinical Lymphoma, Myeloma and Leukemia. 13, 5, p. 552-558 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Immunoglobulin Heavy Chains
Chromosomes, Human, Pair 17
Polyploidy
Tetraploidy
27 Citations (Scopus)

Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype

Rio-Machin, A., Ferreira, B. I., Henry, T., Gómez-López, G., Agirre, X., Alvarez, S., Rodriguez-Perales, S., Prosper, F., Calasanz, M. J., Martínez, J., Fonseca, R. & Cigudosa, J. C., Apr 2013, In : Leukemia. 27, 4, p. 925-931 7 p.

Research output: Contribution to journalArticle

Polyploidy
Multiple Myeloma
MicroRNAs
Down-Regulation
Cyclin D

Genetics of multiple myeloma

Schuster, S., Braggio, E. D. & Fonseca, R., May 1 2013, Genetic and Molecular Epidemiology of Multiple Myeloma. Springer New York, Vol. 9781461446606. p. 1-16 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Multiple Myeloma
MicroRNAs
Epigenomics
Inborn Genetic Diseases
Proteasome Inhibitors
8 Citations (Scopus)
Waldenstrom Macroglobulinemia
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Immunoglobulin M
Lymphoma

Genomic strategies determining progression from MGUS to multiple myeloma

Braggio, E. D. & Fonseca, R., Jan 1 2013, Advances in Biology and Therapy of Multiple Myeloma: Volume 1: Basic Science. Springer New York, p. 3-24 22 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Paraproteinemias
Multiple Myeloma
Inborn Genetic Diseases
Naphazoline
Plasma Cells
33 Citations (Scopus)

Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma

Van Wier, S., Braggio, E. D., Baker, A., Ahmann, G., Levy, J., Carpten, J. D. & Fonseca, R., Oct 1 2013, In : Haematologica. 98, 10, p. 1586-1592 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Polyploidy
Gene Expression Profiling
Monosomy
Comparative Genomic Hybridization
101 Citations (Scopus)

Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma

Rajkumar, S. V., Gupta, V., Fonseca, R., Dispenzieri, A., Gonsalves, W., Larson, D., Ketterling, R. P., Lust, J. A., Kyle, R. A. & Kumar, S. K., Aug 2013, In : Leukemia. 27, 8, p. 1738-1744 7 p.

Research output: Contribution to journalArticle

Immunoglobulin Heavy Chains
Multiple Myeloma
Chromosome Aberrations
Trisomy
Fibrosarcoma

In response

Weber, M. A., Fonseca, R. & Stossel, T. P., Mar 1 2013, In : Endocrine Practice. 19, 2, p. 379 1 p.

Research output: Contribution to journalArticle

In response

Weber, M. A., Black, H. R., Fonseca, R., Garber, J. R., Gonzalez-Campoy, M., Kimmelstiel, C., Markowitz, A. B., Nakayama, D., Stell, L. K. & Stossel, T. P., Mar 1 2013, In : Endocrine Practice. 19, 2, p. 380-381 2 p.

Research output: Contribution to journalArticle

Interprofessional Relations
Professional Ethics
Health Care Sector
Physicians
Interprofessional Relations
Professional Ethics
Medical Assistance
Health Care Sector
Physicians
33 Citations (Scopus)

Lessons from next-generation sequencing analysis in hematological malignancies

Braggio, E. D., Egan, J. B., Fonseca, R. & Stewart, A. K., Jul 2013, In : Blood Cancer Journal. 3, 7

Research output: Contribution to journalArticle

Hematologic Neoplasms
Clonal Evolution
Precision Medicine
Genetic Association Studies
Sequence Analysis
265 Citations (Scopus)
Multiple Myeloma
Guidelines
Plasma Cell Neoplasms
Poisons
Therapeutics

Molecular genetic aspects of plasma cell disorders

Bergsagel, P. L., Stewart, A. K., Russell, S. J. & Fonseca, R., Oct 17 2013, Wintrobe's Clinical Hematology: Thirteenth Edition. Wolters Kluwer Health Adis (ESP), p. 2022-2028 7 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Plasma Cells
Molecular Biology
17 Citations (Scopus)

Myeloma: Classification and risk assessment

Fonseca, R. & Monge, J., Oct 2013, In : Seminars in Oncology. 40, 5, p. 554-566 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Therapeutics
Survival